BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32732837)

  • 1. Minimizing Risks of Liver Transplantation With Steatotic Donor Livers by Preferred Recipient Matching.
    Jackson KR; Motter JD; Haugen CE; Long JJ; King B; Philosophe B; Massie AB; Cameron AM; Garonzik-Wang J; Segev DL
    Transplantation; 2020 Aug; 104(8):1604-1611. PubMed ID: 32732837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes After Declining a Steatotic Donor Liver for Liver Transplant Candidates in the United States.
    Jackson KR; Bowring MG; Holscher C; Haugen CE; Long JJ; Liyanage L; Massie AB; Ottmann S; Philosophe B; Cameron AM; Segev DL; Garonzik-Wang J
    Transplantation; 2020 Aug; 104(8):1612-1618. PubMed ID: 32732838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The "Skinny" on Assessment and Utilization of Steatotic Liver Grafts: A Systematic Review.
    Croome KP; Lee DD; Taner CB
    Liver Transpl; 2019 Mar; 25(3):488-499. PubMed ID: 30817859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study.
    Haugen CE; Thomas AG; Garonzik-Wang J; Massie AB; Segev DL
    Transplantation; 2018 Sep; 102(9):1514-1519. PubMed ID: 29570165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort.
    Croome KP; Lee DD; Croome S; Nakhleh RE; Abader Sedki Senada P; Livingston D; Yataco M; Taner CB
    Liver Transpl; 2019 Oct; 25(10):1533-1540. PubMed ID: 31187923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of the Liver Donor Supply Through Greater Use of Split-Liver Transplantation: Identifying Optimal Recipients.
    Mogul DB; Luo X; Garonzik-Wang J; Bowring MG; Massie AB; Schwarz KB; Cameron AM; Bridges JFP; Segev DL
    Liver Transpl; 2019 Jan; 25(1):119-127. PubMed ID: 30230191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrosteatotic Allografts and Obese Recipients Have Nearly Equal Negative Impact on Liver Transplant Survival.
    Northup PG; Intagliata NM; Davis JPE; Argo CK; Pelletier SJ
    Transplantation; 2020 Jun; 104(6):1193-1200. PubMed ID: 31577675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the Use of Geriatric Livers for Transplantation in the Eurotransplant Region.
    de Boer JD; Blok JJ; Putter H; Koopman JJE; van Hoek B; Samuel U; van Rosmalen M; Metselaar HJ; Alwayn IPJ; Guba M; Braat AE;
    Liver Transpl; 2019 Feb; 25(2):260-274. PubMed ID: 30317683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of steatotic donor livers on the prognosis of donors and recipients after pediatric living donor liver transplantation].
    Yang Y; Dong C; Sun C; Wang K; Zhang W; Zheng WP; Zhang FB; Qin H; Han C; Wang Z; Xu M; Gao W
    Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):922-929. PubMed ID: 36207981
    [No Abstract]   [Full Text] [Related]  

  • 10. Steatotic donor livers: Where is the risk-benefit maximized?
    Hamar M; Selzner M
    Liver Transpl; 2017 Oct; 23(S1):S34-S39. PubMed ID: 28734124
    [No Abstract]   [Full Text] [Related]  

  • 11. Moderately Macrosteatotic Livers Have Acceptable Long-Term Outcomes but Higher Risk of Immediate Mortality.
    Alvikas J; Deeb AP; Jorgensen DR; Minervini MI; Demetris AJ; Lemon K; Chen X; Labiner H; Malik S; Hughes C; Humar A; Tevar A
    Transplant Proc; 2021 Jun; 53(5):1682-1689. PubMed ID: 33931249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Liver Transpl; 2019 Apr; 25(4):598-609. PubMed ID: 30716208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Dual-Kidney Liver Transplantation in the United States: A Review of United Network for Organ Sharing/Organ Procurement and Transplantation Network Data Between 2002 and 2012.
    Shekhtman G; Huang E; Danovitch GM; Martin P; Bunnapradist S
    Liver Transpl; 2018 Nov; 24(11):1570-1577. PubMed ID: 29493877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE; Perkins JD; Reyes JD; Montenovo MI
    Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
    Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
    Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of domino liver transplantation compared to deceased donor liver transplantation: a propensity-matching approach.
    Geyer ED; Burrier C; Tumin D; Hayes D; Black SM; Washburn WK; Tobias JD
    Transpl Int; 2018 Nov; 31(11):1200-1206. PubMed ID: 29907976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longterm results of liver transplantation from donation after circulatory death.
    Blok JJ; Detry O; Putter H; Rogiers X; Porte RJ; van Hoek B; Pirenne J; Metselaar HJ; Lerut JP; Ysebaert DK; Lucidi V; Troisi RI; Samuel U; den Dulk AC; Ringers J; Braat AE;
    Liver Transpl; 2016 Aug; 22(8):1107-14. PubMed ID: 27028896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Retransplantation Associated With Kidney Transplantation for End-stage Liver Graft Disease and Renal Insufficiency: A Morbid Procedure on a Unique Subgroup of Patients.
    Cauchy F; Vibert E; Cherqui D; Perdigao F; Sepulveda A; Samuel D; Calmus Y; Conti F; Adam R; Soubrane O; Scatton O
    Transplantation; 2020 Jul; 104(7):1403-1412. PubMed ID: 31651789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.
    Celik N; Kelly B; Soltys K; Squires JE; Vockley J; Shellmer DA; Strauss K; McKiernan P; Ganoza A; Sindhi R; Bond G; Mazariegos G; Khanna A
    Clin Transplant; 2019 Nov; 33(11):e13721. PubMed ID: 31556146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.